A Prospective Study on Eﬀect of High Dose of Steroid on Platelet Count in Acute Stage of Dengue Fever with Thrombocytopenia
Role of Steroid in Dengue Fever
Background: Dengue was the second disease after “yellow fever” that was shown to be caused by virus. The present study was conducted to assess effect of steroid on platelet count in acute stage of dengue fever. Subjects and Methods: 112 patients of dengue fever were divided into 2 groups. Group I was prescribed intravenous dexamethasone 8 mg initially followed by 4 mg every 8 hours thereafter for 4 days and group II patients was given only IV fluids and antipyretics. Results: Group I had 30 males and 26 females and group II had 25 males and 27 females. The mean platelet count (thousands) in day 1 was 29846.8 and 32442.4 in group I and group II respectively, on day 2 was 56003.4 and 44284.6, on day 3 was 78012.6 and 74224.6 and on day 4 was 126124.8 and 114620.4. The difference between both groups was non- significant (P> 0.05). Conclusion: High dose dexamethasone regimen was not effective in achieving a higher rise in the platelet count in the acute stage of dengue fever.
Heilman JM, Wolff JD, Beards GM, Basden BJ. Dengue fever: a Wikipedia clinical review. Open Med. 2014;8(4):e105–e115.
Stasi R, Provan D. Management of Immune Thrombocytopenic Purpura in Adults. Mayo Clinic Proceedings. 2004;79(4):504–522. Available from: https://dx.doi.org/10.4065/79.4.504.
Messer WB, Vitarana UT, Elvtigala J, Sivananthan K, Preethi- mala LD, Ramesh R, et al. Epidemiology of dengue in Sri Lanka before and after the emergence of epidemic dengue hem- orrhagic fever. Am J Trop Med Hyg. 2002;66(6):765–773. Available from: https://dx.doi.org/10.4269/ajtmh.2002.66.765.
Halstead SB. Dengue. Lancet. 2007;370(9599):1644– 1652. Available from: https://dx.doi.org/10.1016/s0140-6736(07)61687-0.
Sligl WI, Danny A Milner J, Sundar S, Mphatswe W, Majumdar SR. Safety and Efficacy of Corticosteroids for the Treatment of Septic Shock: A Systematic Review and Meta-Analysis. Clin Infect Dis. 2009;49(1):93–101. Available from: https://dx.doi.org/10.1086/599343.
Minneci PC, Deans KJ, Eichacker PQ. The effects of steroids during sepsis depend on dose and severity of illness: An updated meta-analysis. Clin Microbiol Infect. 1984;15:1137– 1180. Available from: https://doi.org/10.1111/j.1469-0691.2009.02752.x.
Sprung CL, Caralis PV, Marcial EH, Pierce M, Gelbard MA, Long WM, et al. The Effects of High-Dose Corti- costeroids in Patients with Septic Shock. N Engl J Med. 1984;311(18):1137–1143. Available from: https://dx.doi.org/10.1056/nejm198411013111801.
Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, and RAB. A Controlled Clinical Trial of High-Dose Methylprednisolone in the Treatment of Severe Sepsis and Septic Shock. N Engl J Med. 1987;317(11):653–658. Available from: https://dx.doi.org/10.1056/nejm198709103171101.
Panpanich R, Sornchai P, Kanjanaratanakorn K. Corticos- teroids for treating dengueshock syndrome. Cochrane Database Syst Rev. 2006;(3):3488.
Kularatne S. Survey on the management of dengue infection in Sri Lanka: Opinion of physicians and pediatricians. Southeast Asian J Trop Med Pub Health. 2005;36:1198–200.
Shashidhara KC. Effect of High Dose of Steroid on Platelet- count in Acute Stage of Dengue Fever with Thrombocytope- nia. J Clin Diagn Res. 2013;7(7):1397. Available from: https://dx.doi.org/10.7860/jcdr/2013/6135.3143.
Lefering R, Neugebauer EAM. Steroid controversy in sepsis and septic shock. Critical Care Med. 1995;23(7):1294– 1303. Available from: https://dx.doi.org/10.1097/00003246-199507000-00021.
Copyright (c) 2020 Author
This work is licensed under a Creative Commons Attribution 4.0 International License.